CRISPR-Based Diagnostic Assay for Point-of-Care Detection of Methicillin-Resistant Staphylococcus aureus in patients with Bloodstream Infections
ACS Sensors · 2026
DOI: 10.1021/acssensors.6c01650 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Hai-Qian Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai200127, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Point-of-Care Systems, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Jiao Tong University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of mortality in critically ill patients with bloodstream infections (BSIs). Timely diagnosis and early initiation of guideline-concordant antimicrobial therapy are independently associated with improved survival and reduced complication rates in patients with MRSA BSIs. However, current blood culture-based detection of MRSA requires 3–7 days for definitive identification and antimicrobial susceptibility reporting, entails numerous manual steps, and frequently delays the transition from empirical to pathogen-directed therapy, thereby affecting treatment outcomes and patient prognosis. Here, we present a highly sensitive and specific CRISPR-based diagnostic platform that shortens the MRSA detection time from >70 h to ∼2 h—enabling true "sample-to-result" testing directly from whole blood at the point of care. This study develops a one-step RPA-CRISPR assay targeting the S. aureus nucA and mecA genes, with 10 copies/reaction sensitivity and no cross-reactivity. By integrating vancomycin-conjugated magnetic nanoparticles, a herringbone microfluidic chip, and a miniaturized wireless analyzer, the platform performs on-chip S. aureus capture, lysis-mediated DNA release, and dual-gene detection directly from whole blood. In a prospective, multicenter clinical evaluation of 350 hospitalized patients with suspected bacteremia, the HELP platform identified all 20 S. aureus-positive cases (including 8 MRSA-positive cases), demonstrating 100% positive percent agreement with blood culture. By delivering definitive MRSA identification in under 2 h, HELP markedly accelerates clinical decision-making, facilitates the timely initiation of targeted antimicrobial therapy, and holds strong potential for scalable deployment in primary care and resource-constrained settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai200127, China.
- Clinical Laboratory, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing400014, China.
- College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai200025, China.
- Shanghai Public Health Clinical Center, Fudan University, Shanghai201508, China.
ORCID-Profile: Hua Wang
Förderung
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- National Key Research and Development Program of China
Zitieren
APA
Huang, H. Q., Zhang, J. H., Hu, X. F., Xu, J. S., Liu, Y., Yang, S., Li, T. M., Zhu, Z. Y., Li, S., Li, W., Li, M., & Wang, H. (2026). CRISPR-Based Diagnostic Assay for Point-of-Care Detection of Methicillin-Resistant Staphylococcus aureus in patients with Bloodstream Infections. ACS Sensors. https://doi.org/10.1021/acssensors.6c01650
Vancouver
Huang HQ, Zhang JH, Hu XF, Xu JS, Liu Y, Yang S, et al. CRISPR-Based Diagnostic Assay for Point-of-Care Detection of Methicillin-Resistant Staphylococcus aureus in patients with Bloodstream Infections. ACS Sensors. 2026. doi:10.1021/acssensors.6c01650
BibTeX
@article{Huang2026,
author = {Huang, Hai-Qian and Zhang, Jun-Heng and Hu, Xie-Fei and Xu, Jing-Song and Liu, Yu and Yang, Shuang and Li, Tian-Ming and Zhu, Zi-Yue and Li, Shun and Li, Wei and Li, Min and Wang, Hua},
title = {CRISPR-Based Diagnostic Assay for Point-of-Care Detection of Methicillin-Resistant Staphylococcus aureus in patients with Bloodstream Infections},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c01650}
}
EUVIMED